![Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC](https://europepmc.org/articles/PMC2422995/bin/cuaj1377T2.jpg)
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC
![When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/01/table1.png)
When should the patient and doctor consider salvage radiation therapy? | THE "NEW" PROSTATE CANCER INFOLINK
![Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-021-00372-x/MediaObjects/41391_2021_372_Fig1_HTML.png)
Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases
![ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial](https://larvolclin.s3.us-west-2.amazonaws.com/resize_166306090938969400863204badaece6.png)
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![Cancers | Free Full-Text | The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes Cancers | Free Full-Text | The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes](https://pub.mdpi-res.com/cancers/cancers-13-02453/article_deploy/html/images/cancers-13-02453-g001-550.jpg?1621391413)
Cancers | Free Full-Text | The Significance of Prostate Specific Antigen Persistence in Prostate Cancer Risk Groups on Long-Term Oncological Outcomes
![PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4f9582669148cbf9cf6d6ab28497bdbda8615c3/3-Table1-1.png)
PDF] Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. | Semantic Scholar
![Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction](https://www.mdpi.com/cancers/cancers-13-03381/article_deploy/html/images/cancers-13-03381-g001.png)
Cancers | Free Full-Text | Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
![Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article](https://assets.cureus.com/uploads/figure/file/29242/a099e0804c6f11e883b9bd01db8ff489-Figure1.png)
Cureus | Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints | Article
![Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis](https://www.mdpi.com/cancers/cancers-12-02180/article_deploy/html/images/cancers-12-02180-g001.png)
Cancers | Free Full-Text | Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t4.gif)